These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

195 related items for PubMed ID: 15720812

  • 1. Phosphorylation of both EGFR and ErbB2 is a reliable predictor of prostate cancer cell proliferation in response to EGF.
    El Sheikh SS, Domin J, Abel P, Stamp G, Lalani el-N.
    Neoplasia; 2004; 6(6):846-53. PubMed ID: 15720812
    [Abstract] [Full Text] [Related]

  • 2. Epidermal growth factor receptor, c-erbB2 and c-erbB3 receptor interaction, and related cell cycle kinetics of SK-BR-3 and BT474 breast carcinoma cells.
    Brockhoff G, Heiss P, Schlegel J, Hofstaedter F, Knuechel R.
    Cytometry; 2001 Aug 01; 44(4):338-48. PubMed ID: 11500850
    [Abstract] [Full Text] [Related]

  • 3. Gefitinib ('IRESSA', ZD1839) inhibits EGF-induced invasion in prostate cancer cells by suppressing PI3 K/AKT activation.
    Bonaccorsi L, Marchiani S, Muratori M, Forti G, Baldi E.
    J Cancer Res Clin Oncol; 2004 Oct 01; 130(10):604-14. PubMed ID: 15258753
    [Abstract] [Full Text] [Related]

  • 4. Sensitivity to gefitinib (Iressa, ZD1839) in non-small cell lung cancer cell lines correlates with dependence on the epidermal growth factor (EGF) receptor/extracellular signal-regulated kinase 1/2 and EGF receptor/Akt pathway for proliferation.
    Ono M, Hirata A, Kometani T, Miyagawa M, Ueda S, Kinoshita H, Fujii T, Kuwano M.
    Mol Cancer Ther; 2004 Apr 01; 3(4):465-72. PubMed ID: 15078990
    [Abstract] [Full Text] [Related]

  • 5. Blockade of epidermal growth factor- or heregulin-dependent ErbB2 activation with the anti-ErbB2 monoclonal antibody 2C4 has divergent downstream signaling and growth effects.
    Jackson JG, St Clair P, Sliwkowski MX, Brattain MG.
    Cancer Res; 2004 Apr 01; 64(7):2601-9. PubMed ID: 15059917
    [Abstract] [Full Text] [Related]

  • 6. Epidermal growth factor (EGF) receptor kinase-independent signaling by EGF.
    Deb TB, Su L, Wong L, Bonvini E, Wells A, David M, Johnson GR.
    J Biol Chem; 2001 May 04; 276(18):15554-60. PubMed ID: 11279155
    [Abstract] [Full Text] [Related]

  • 7. Growth hormone-induced phosphorylation of epidermal growth factor (EGF) receptor in 3T3-F442A cells. Modulation of EGF-induced trafficking and signaling.
    Huang Y, Kim SO, Jiang J, Frank SJ.
    J Biol Chem; 2003 May 23; 278(21):18902-13. PubMed ID: 12642595
    [Abstract] [Full Text] [Related]

  • 8. Resistance to small molecule inhibitors of epidermal growth factor receptor in malignant gliomas.
    Li B, Chang CM, Yuan M, McKenna WG, Shu HK.
    Cancer Res; 2003 Nov 01; 63(21):7443-50. PubMed ID: 14612544
    [Abstract] [Full Text] [Related]

  • 9. Involvement of MAP-kinase, PI3-kinase and EGF-receptor in the stimulatory effect of Neurotensin on DNA synthesis in PC3 cells.
    Hassan S, Dobner PR, Carraway RE.
    Regul Pept; 2004 Aug 15; 120(1-3):155-66. PubMed ID: 15177934
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. PTEN expression controls cellular response to cetuximab by mediating PI3K/AKT and RAS/RAF/MAPK downstream signaling in KRAS wild-type, hormone refractory prostate cancer cells.
    Bouali S, Chrétien AS, Ramacci C, Rouyer M, Becuwe P, Merlin JL.
    Oncol Rep; 2009 Mar 15; 21(3):731-5. PubMed ID: 19212633
    [Abstract] [Full Text] [Related]

  • 15. Role of somatostatin receptor 1 and 5 on epidermal growth factor receptor mediated signaling.
    Kharmate G, Rajput PS, Watt HL, Somvanshi RK, Chaudhari N, Qiu X, Kumar U.
    Biochim Biophys Acta; 2011 Jun 15; 1813(6):1172-89. PubMed ID: 21419811
    [Abstract] [Full Text] [Related]

  • 16. Grape seed extract inhibits EGF-induced and constitutively active mitogenic signaling but activates JNK in human prostate carcinoma DU145 cells: possible role in antiproliferation and apoptosis.
    Tyagi A, Agarwal R, Agarwal C.
    Oncogene; 2003 Mar 06; 22(9):1302-16. PubMed ID: 12618755
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Molecular aspects of gefitinib antiproliferative and pro-apoptotic effects in PTEN-positive and PTEN-negative prostate cancer cell lines.
    Festuccia C, Muzi P, Millimaggi D, Biordi L, Gravina GL, Speca S, Angelucci A, Dolo V, Vicentini C, Bologna M.
    Endocr Relat Cancer; 2005 Dec 06; 12(4):983-98. PubMed ID: 16322337
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. ERK1/2 mediate wounding- and G-protein-coupled receptor ligands-induced EGFR activation via regulating ADAM17 and HB-EGF shedding.
    Yin J, Yu FS.
    Invest Ophthalmol Vis Sci; 2009 Jan 06; 50(1):132-9. PubMed ID: 18658095
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.